Results 131 to 140 of about 2,196,135 (231)

Plaque heterogeneity and the spatial distributions of its components dictate drug-coated balloon therapy

Scientific Reports
Drug-coated balloon (DCB) angioplasty is one of the potential approaches to alleviating in-stent restenosis and treating peripheral artery disease. An in-silico model has been developed for sirolimus drug eluted from an inflated balloon in a patient ...
Sarifuddin, P. Mandal
semanticscholar   +1 more source

Drug-Coated Balloon Treatment for De Novo Coronary Lesions: Current Status and Future Perspectives

Korean Circulation Journal
Author's summary Percutaneous coronary intervention with drug-eluting stents has improved safety and efficacy, but recurrent events such as late stent thrombosis and restenosis underscore the need for alternative treatments.
A. Her, Eun-Seok Shin
semanticscholar   +1 more source

Drug-coated balloon therapy in coronary and peripheral artery disease.

, 2014
Nonstent-based local drug delivery during percutaneous intervention offers potential for sustained antirestenotic efficacy without the limitations of permanent vascular implants.
Byrne, Robert A;Joner, Michael;Alfonso, Fernando;Kastrati, Adnan
core   +1 more source

Drug-Coated Balloons Beyond In-Stent Restenosis

Reviews in Cardiovascular Medicine
Drug-coated balloons (DCBs) are rapidly gaining prominence, owing to the associated expanding clinical applications and therapeutic potential in interventional cardiology. Moreover, a growing body of evidence from randomized trials, observational studies,
Rahul Gupta, Chandrashekar Bohra, Krishna Santosh Vemuri, Gaurav Arora, Amit Gulati, Isha Ranadive, Samin K. Sharma, Amit Hooda   +7 more
doaj   +1 more source

Hydrophilic Coating Microstructure Mediates Acute Drug Transfer in Drug-Coated Balloon Therapy

ACS Applied Bio Materials
Drug-coated balloon (DCB) therapy is a promising endovascular treatment for obstructive arterial disease. The goal of DCB therapy is restoration of lumen patency in a stenotic vessel, whereby balloon deployment both mechanically compresses the offending ...
T. Shazly, J. Eberth, Colton J. Kostelnik, Mark J. Uline, V. Chitalia, F. Spinale, Ahmed Alshareef, Vijaya B. Kolachalama   +7 more
semanticscholar   +1 more source

Paclitaxel- or sirolimus-coated balloons used for ArterioVEnous fistulas-2 (PAVE-2): study protocol for a randomised controlled trial to determine the efficacy of paclitaxel- or sirolimus-coated balloons in arteriovenous fistulas used for haemodialysis

Trials
Background In view of the conflicting results from previous studies, the benefit of paclitaxel-coated balloons for arteriovenous fistulas is uncertain and equipoise remains. Although an industry-led trial testing the efficacy of sirolimus-coated balloons
Narayan Karunanithy, Sam Norton, Francis Calder, Neelanjan Das, Niamh Dooley, Lusine Hakobyan, Robert Jones, Soundrie Padayache, Chloe Spriggs, Kate Steiner, Rebecca Suckling, Michael G. Robson   +11 more
doaj   +1 more source

Chinese expert consensus on the clinical application of drug-coated balloon (2nd Edition).

Journal of Geriatric Cardiology
Percutaneous coronary interventions have progressed through the era of plain balloon dilation, bare-metal stent insertion to drug-eluting stent treatment, which has significantly reduced the acute occlusion and restenosis rates of target vessels and ...
J. Ge, Yun-Dai Chen
semanticscholar   +1 more source

Hybrid in silico and ex vivo models for quantitative evaluation of acute coating transfer in Drug-Coated Balloon angioplasty

DOTTORATODrug-coated balloons (DCBs) have emerged as promising devices for treating cardiovascular diseases, offering localized drug delivery during angioplasty while supporting the "leave nothing behind" strategy.
STRATAKOS, EFSTATHIOS
core  

Effectiveness and safety of drug-coated balloon in patients with acute ST-segment elevation myocardial infarction during interventional therapy

Journal of Cardiothoracic Surgery
Objective This investigation seeks to assess the efficacy and safety profile of drug-coated balloon (DCB) and drug-eluting stent (DES) throughout primary percutaneous coronary intervention (PCI) among individuals with ST-segment elevation myocardial ...
Yajing Liu, Jinyan Chen, Da Yuan, Zizhou Jia, Jia Li, Jing Ma   +5 more
doaj   +1 more source

The compounding effects of obesity on the development of Intimal Hyperplasia following vascular intervention : a histopathological analysis [PDF]

, 2009
Includes abstract.Includes bibliographical references (leaves 100-111).This study examines the histopathological response to injury following both balloon angioplasty and endovascular stenting in the Zucker rat, a model that allows interpretation of the ...
Black, Melanie Kim
core